NumFin

PetMed Express, Inc.

Sümbol: PETS

NASDAQ

4.83

USD

Turuhind täna

  • -10.2303

    P/E suhe

  • -0.1857

    PEG suhe

  • 102.14M

    MRK Cap

  • 0.15%

    DIV tootlus

PetMed Express, Inc. (PETS) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete PetMed Express, Inc. (PETS) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 191.045 M, mis on 0.172 % gowth. Kogu perioodi keskmine brutokasum on 65.088 M, mis on 0.170 %. Keskmine brutokasumi suhtarv on 0.355 %. Ettevõtte eelmise aasta tulemuse puhaskasv on -0.989 %, mis on võrdne 0.202 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes PetMed Express, Inc. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus -0.069. Käibevara valdkonnas on PETS aruandlusvaluutas 131.451. Märkimisväärne osa neist varadest, täpsemalt 104.086, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust -0.063%. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 0 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on 0.000%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 123.795 aruandlusvaluutas. Selle aspekti aastane muutus on -0.129%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 1.74, varude hind on 19.02 ja firmaväärtus 0, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 5.86.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000

balance-sheet.row.cash-and-short-term-investments

268.53104.1111.1118.7
103.8
100.5
77.9
58.7
37.6
51.2
33.8
33.6
57.1
59.8
53.1
30.1
25
39.4
23.2
12.7
3.3
1
0.7
0.4
0.3

balance-sheet.row.short-term-investments

0000
0
0
0
0
0
15.6
15.5
15.5
10.3
10.1
0
0
4.8
39.1
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

7.741.71.92.6
3.8
2.5
2.3
1.8
1.7
1.9
1.8
1.4
1.6
2
2.1
2.9
1.6
1.4
1.2
1.8
1.1
0.7
0.3
0.2
0.2

balance-sheet.row.inventory

104.831932.534.4
17.9
21.4
23.3
20.2
25.6
25.1
35.7
31.6
26.2
25.1
29.1
26.8
17.9
16.1
15
11.2
11.2
4.3
2.3
0.6
1.8

balance-sheet.row.other-current-assets

32.514.75.54.5
3.5
1.4
0.9
1
2.4
1.4
1.8
2.5
2.7
2.7
2.2
0.7
0.7
1.1
0.6
0.2
0.2
0.5
0.1
0
0.7

balance-sheet.row.total-current-assets

418.49131.5151161.2
129
126.4
105.2
81.8
67.6
80.4
74.2
70.2
87.6
89.6
86.5
61.6
45.2
58
40
25.9
15.8
6.4
3.5
1.2
2.9

balance-sheet.row.property-plant-equipment-net

112.6426.224.525.4
25.4
27.1
28.7
30.2
20.9
1.6
1.3
2.1
2.6
3.4
4.4
5.1
1.9
2
1.5
1.3
1.7
1.5
1.1
3.2
3.3

balance-sheet.row.goodwill

69.84000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

52.45.90.90.9
0.9
0.9
0.9
0.9
0.9
0.9
0.9
0.9
0.9
0.9
0.8
0.8
0.4
0.4
0.4
0.4
0.4
0.4
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

122.255.90.90.9
0.9
0.9
0.9
0.9
0.9
0.9
0.9
0.9
0.9
0.9
0.8
0.8
0.4
0.4
0.4
0.4
0.4
0.4
0
0
0

balance-sheet.row.long-term-investments

9.44-5.924.325.6
25.5
0
0
0
0
0
-1.1
0
0
12.4
12.4
14.4
25
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

18.80.61.10.8
0.8
0
0
0
0.9
0
1.1
1
1.2
1
1.3
0.7
1.2
0.9
0.8
0.6
0.6
0.6
0
0
0

balance-sheet.row.other-non-current-assets

-4.145.9-25.3-26.3
-26.3
-28
0
0
0
0
2
-1
-1.2
-1
-1.3
-0.7
-0.3
0
0
0
0
0.2
0.1
0.1
0.1

balance-sheet.row.total-non-current-assets

258.9832.725.326.3
26.3
28
29.6
31
22.7
2.5
4.2
3
3.5
16.7
17.7
20.3
28.2
3.3
2.7
2.2
2.7
2.6
1.2
3.3
3.4

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

677.48164.1176.3187.5
155.3
154.4
134.8
112.8
90.3
82.9
78.4
73.2
91.1
106.3
104.2
82
73.5
61.2
42.6
28.1
18.5
9
4.7
4.5
6.3

balance-sheet.row.account-payables

129.4725.227.539.5
19.7
16.3
15.3
15.2
5
5.2
5.8
6.5
6.6
6.5
4.8
4.8
4.4
5.9
3.1
2.7
3.3
3.3
2.7
1.5
1.3

balance-sheet.row.short-term-debt

2.31000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0.1
0.1
1.9
1

balance-sheet.row.tax-payables

29.061.91.21
0.5
0.4
0.5
0.7
0.5
0.1
0.5
0.2
0.2
0.7
0.3
0.4
0.2
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

3.24000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0.3
0
1.8

Deferred Revenue Non Current

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

2.53---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

65.2411.35.75.4
4.7
2.4
2.8
3.1
2.1
2.3
2.3
2.5
2.8
2.5
2.3
2.2
2.1
1.5
1.9
1.2
0.4
0
0
0.3
0.2

balance-sheet.row.total-non-current-liabilities

14.713.80.91.3
1
1.1
1
1.1
5
5.2
0.1
0.2
0.5
0.3
0.2
4.8
4.4
5.9
3.1
2.7
3.3
0.1
0.3
0
2.2

balance-sheet.row.other-liabilities

0000
0
0
0
0
-5
-5.2
0
0
0
0
0
-4.8
-4.4
-5.9
-3.1
-2.7
-3.3
0
0
0
0

balance-sheet.row.capital-lease-obligations

4.79000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

221.6340.334.146.2
25.3
19.7
19.1
19.4
7.1
7.4
8.2
9.2
9.9
9.3
7.3
7
6.4
7.4
5
3.9
4.5
3.4
3.1
3.7
4.7

balance-sheet.row.preferred-stock

0.04000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0.08000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

372.18105.5130.5134.1
126.2
122.2
106.3
86.5
78.3
72.3
68.6
64
81.1
97.1
94.3
75.2
58.6
38.6
24.2
12.1
4.1
-1.7
-5
-5.8
-3

balance-sheet.row.accumulated-other-comprehensive-income-loss

-0.03000
0
-8.4
-6.2
-4
-8.4
-0.1
0
0
0
-0.1
-0.1
-0.2
-2.9
-2.3
-1.8
-2
-1.4
-0.8
-0.8
-0.8
0

balance-sheet.row.other-total-stockholders-equity

83.5818.311.77.1
3.8
20.9
15.6
10.9
13.3
3.1
1.6
0
0
0
2.6
0
11.3
17.5
15.2
14
11.3
8.1
7.4
7.3
4.6

balance-sheet.row.total-stockholders-equity

455.85123.8142.2141.3
130
134.7
115.7
93.4
83.2
75.4
70.2
64
81.2
97
96.9
75
67
53.9
37.6
24.2
14
5.6
1.6
0.8
1.6

balance-sheet.row.total-liabilities-and-stockholders-equity

677.48164.1176.3187.5
155.3
154.4
134.8
112.8
90.3
82.9
78.4
73.2
91.1
106.3
104.2
82
73.5
61.2
42.6
28.1
18.5
9
4.7
4.5
6.3

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

455.85123.8142.2141.3
130
134.7
115.7
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

677.48---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

9.44-5.924.325.6
25.5
0
0
0
0
15.6
15.5
15.5
10.3
22.5
12.4
14.4
29.8
39.1
0
0
0
0
0
0
0

balance-sheet.row.total-debt

5.55000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0.1
0.3
2
2.8

balance-sheet.row.net-debt

-262.99-104.1-111.1-118.7
-103.8
-100.5
-77.9
-58.7
-37.6
-35.6
-18.3
-18.2
-46.8
-49.7
-53.1
-30.1
-20.3
-0.3
-23.2
-12.7
-3.2
-0.8
-0.4
1.5
2.5

Rahavoogude aruanne

PetMed Express, Inc. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab 0.346 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 0, mis tähistab 0.000 erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli -10260000.000. See on 4.856 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 3.55, 5, 0, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte -24.54 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui 0, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000

cash-flows.row.net-income

-8.090.221.130.6
25.9
37.7
37.3
23.8
20.6
17.5
18
17.2
16.7
20.9
26
23
20
14.4
12.1
8
5.8
3.3
0.8
-2.8
-1.8

cash-flows.row.depreciation-and-amortization

6.163.52.72.4
2.3
2.2
2.1
1.4
0.8
0.7
0.9
1.1
1.4
1.4
1.3
0.8
0.6
0.5
0.5
0.6
0.6
0.4
0.2
-0.1
-0.2

cash-flows.row.deferred-income-tax

-1.53-1.6-0.30.3
-0.2
0.1
-0.1
2
0
0.2
-0.2
-0.1
-0.1
0.3
-0.3
0.5
-0.3
-0.1
-0.2
0
0
-0.6
0
0
0

cash-flows.row.stock-based-compensation

6.836.64.53.3
2.8
3.1
2.6
1.9
1.6
1.5
1.5
1.9
2.2
2.2
1.6
1.5
1.7
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

3.0418.8-9.73.3
7.9
1.9
-4.6
17.7
-2.1
10.5
-6.7
-6.9
0.1
5.3
-0.9
-10.9
-2.6
0.6
-2.5
-1.2
-5.9
-2.2
-0.9
1.9
1

cash-flows.row.account-receivables

0.1600.51.1
-1.5
-0.3
-0.6
-0.5
-0.1
-0.3
-0.4
0.1
0.4
0.1
0.8
-1.4
-0.2
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-9.0613.42-16.5
3.5
2
-3.1
5.4
-0.5
10.7
-4.1
-5.4
-1.1
3.9
-2.3
-8.9
-1.8
-1.1
-3.8
0
-6.9
-2
-1.7
1.1
-0.2

cash-flows.row.account-payables

8.82-2.3-1219.9
3.4
1
0.1
10.2
-0.1
-0.6
-0.7
-0.2
0.3
2
0.3
-0.3
-1.5
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

3.11-11.1-0.1-1.2
2.5
-0.8
-1
2.6
-1.4
0.7
-1.5
-1.4
0.5
-0.7
0.3
-0.3
0.9
1.7
1.4
-1.2
1.1
-0.3
0.8
0.8
1.2

cash-flows.row.other-non-cash-items

0.510.20.20.1
0.2
0.1
0.1
0.4
0.3
1.8
0.1
0.1
0
0
0
0.1
0
1.1
0.3
0.9
0.6
0.2
0.3
0
0.6

cash-flows.row.net-cash-provided-by-operating-activities

6.92000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-5.19-5.3-1.8-2.4
-2.3
-0.6
-0.7
-10.6
-20.1
-0.9
0
-0.6
-0.7
-0.7
-1
-3.7
-0.5
-1
-0.8
-0.2
-0.7
-0.7
-0.6
-0.2
-0.6

cash-flows.row.acquisitions-net

-26.16-500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

4.7-500
0
0
0
0
0
-0.1
-0.1
-5.2
0
0
0
0
0
-16.3
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
0
0
0
0
15.6
0
0
0
0
0
2.1
14.9
9.6
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

-14.7500
0
0
0
0
0
0
0
0
12.3
-10.1
0
0
0
0
0
0
0
-0.3
2
0.3
-0.4

cash-flows.row.net-cash-used-for-investing-activites

-41.35-10.3-1.8-2.4
-2.3
-0.6
-0.7
-10.6
-4.5
-1
-0.1
-5.8
11.6
-10.8
1.1
11.2
9.1
-17.3
-0.8
-0.2
-0.7
-1.1
1.5
0.1
-0.9

cash-flows.row.debt-repayment

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0
2.8
0.4
1
1.3
2
0.6
0
2
0.3

cash-flows.row.common-stock-repurchased

0000
-11.5
0
0
0
0
0
-3.9
-3.9
-23.7
-12.2
0
-18.4
-11.6
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

-18.55-24.5-24.4-22.7
-21.8
-21.9
-17.5
-15.5
-14.7
-13.8
-13.3
-32
-11
-10.7
-6.8
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

0000
-11.5
0
0
0
0.1
0.1
4
-0.3
-0.2
0.2
1
2.2
0.3
0.2
0
-0.1
-0.1
-0.2
-1.6
-0.9
0.6

cash-flows.row.net-cash-used-provided-by-financing-activities

-18.55-24.5-24.4-22.7
-33.3
-21.9
-17.5
-15.5
-14.5
-13.7
-13.2
-36.1
-34.9
-22.8
-5.8
-16.3
-8.5
0.7
1
1.2
1.9
0.4
-1.6
1.1
0.9

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

-52.99-7-7.615
3.2
22.6
19.2
21.1
2
17.3
0.1
-28.6
-2.9
-3.5
23
9.9
20
-0.1
10.5
9.4
2.3
0.2
0.3
0.1
-0.4

cash-flows.row.cash-at-end-of-period

268.53104.1111.1118.7
103.8
100.5
77.9
58.7
37.6
35.6
18.3
18.2
46.8
49.7
53.1
30.1
20.3
0.3
23.2
12.7
3.3
1
0.7
0.4
0.3

cash-flows.row.cash-at-beginning-of-period

321.52111.1118.7103.8
100.5
77.9
58.7
37.6
35.6
18.3
18.2
46.8
49.7
53.1
30.1
20.3
0.3
0.4
12.7
3.3
1
0.7
0.4
0.3
0.7

cash-flows.row.operating-cash-flow

6.9227.818.540.1
38.8
45.1
37.4
47.2
21.1
32
13.5
13.3
20.4
30.1
27.7
15
19.4
16.6
10.3
8.3
1.1
1
0.5
-1
-0.3

cash-flows.row.capital-expenditure

-5.19-5.3-1.8-2.4
-2.3
-0.6
-0.7
-10.6
-20.1
-0.9
0
-0.6
-0.7
-0.7
-1
-3.7
-0.5
-1
-0.8
-0.2
-0.7
-0.7
-0.6
-0.2
-0.6

cash-flows.row.free-cash-flow

1.7222.516.737.6
36.5
44.5
36.7
36.6
0.9
31.1
13.5
12.7
19.7
29.4
26.6
11.3
18.9
15.5
9.5
8.2
0.4
0.2
-0.1
-1.3
-0.9

Kasumiaruande rida

PetMed Express, Inc. tulud muutusid võrreldes eelmise perioodiga -0.061%. PETS brutokasum on teatatud 71.01. Ettevõtte tegevuskulud on 72.44, mille muutus võrreldes eelmise aastaga on 38.342%. Kulud amortisatsioonikulud on 3.55, mis on 0.295% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 72.44, mis näitab 38.342% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab -1.056% kasvu võrreldes eelmise aastaga. Tegevustulu on -1.43, mis näitab -1.056% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on -0.989%. Eelmise aasta puhaskasum oli 0.23.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000

income-statement-row.row.total-revenue

276.97256.9273.4309.2
284.1
283.4
273.8
249.2
234.7
229.4
233.4
227.8
238.3
231.6
238.3
219.4
188.3
162.2
137.6
108.4
94
55
32
10
14.7

income-statement-row.row.cost-of-revenue

200.08185.8195.3219.3
202.9
188.1
176
169.9
158.4
153.1
155.8
150.7
158.1
147.7
146.4
134.1
114.1
97.7
83.2
64.7
55.8
31.5
18.9
6.4
9.1

income-statement-row.row.gross-profit

76.887178.189.9
81.2
95.3
97.8
79.3
76.3
76.3
77.6
77.1
80.2
84
91.9
85.3
74.2
64.6
54.3
43.7
38.2
23.5
13.1
3.6
5.6

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

61.36---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

23.09---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

2.053.52.72.4
2.3
1.1
1
0.3
0.1
0
0
0
1.4
1.4
1.3
0.8
0.6
0.5
0.5
0.6
0.6
0.4
0.6
0.4
-0.2

income-statement-row.row.operating-expenses

88.8472.452.452.4
50.3
49.1
45.7
41.8
43.9
46.9
49.4
50.1
54.1
50.9
51.3
51.1
46.2
43.1
36.2
31.2
29
20
12.4
6.3
7.2

income-statement-row.row.cost-and-expenses

288.92258.3247.7271.6
253.1
237.2
221.7
211.7
202.3
200.1
205.2
200.8
212.2
198.6
197.7
185.2
160.3
140.7
119.4
95.9
84.8
51.5
31.3
12.6
16.3

income-statement-row.row.interest-income

2.182.10.30.3
1.7
1.9
0.7
0.1
0.2
0.2
0.2
0.3
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

-1.08-30.30
0
-2.9
-1.7
-0.4
-0.2
-0.2
-0.2
-0.3
-0.3
-0.3
-0.2
-1.5
-2.4
-1.7
-0.9
-0.1
0
0
0
0.2
0

income-statement-row.row.selling-and-marketing-expenses

23.09---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

1.4731.41.6
2.9
1.1
1
0.3
0
-1.7
0
0
0.1
-0.1
0
0.4
0.6
0.4
0.2
0
0
0
-0.1
0
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

2.053.52.72.4
2.3
1.1
1
0.3
0.1
0
0
0
1.4
1.4
1.3
0.8
0.6
0.5
0.5
0.6
0.6
0.4
0.6
0.4
-0.2

income-statement-row.row.total-operating-expenses

1.4731.41.6
2.9
1.1
1
0.3
0
-1.7
0
0
0.1
-0.1
0
0.4
0.6
0.4
0.2
0
0
0
-0.1
0
0

income-statement-row.row.interest-expense

-1.08-30.30
0
-2.9
-1.7
-0.4
-0.2
-0.2
-0.2
-0.3
-0.3
-0.3
-0.2
-1.5
-2.4
-1.7
-0.9
-0.1
0
0
0
0.2
0

income-statement-row.row.depreciation-and-amortization

6.163.52.72.4
2.3
2.2
2.1
1.4
0.8
0.7
0.9
1.1
1.4
1.4
1.3
0.8
0.6
0.5
0.5
0.6
0.6
0.4
0.2
-0.1
-0.2

income-statement-row.row.ebitda-caps

-5.8---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-11.96-1.425.737.6
31
46.2
52.1
37.5
32.4
27.6
28.2
27
26
33
40.5
34.2
28
21.5
18.1
12.5
9.2
3.5
0.7
-2.6
-1.6

income-statement-row.row.income-before-tax

-9.291.627.139.2
33.9
49.1
53.8
37.9
32.6
27.8
28.4
27.3
26.4
33.3
40.7
35.7
30.4
23.2
19
12.6
9.2
3.5
0.8
-2.8
-1.6

income-statement-row.row.income-tax-expense

-1.211.468.6
8
11.4
16.5
14.1
12
10.3
10.4
10.1
9.7
12.4
14.7
12.7
10.4
8.8
7
4.6
3.4
0.2
-0.1
0.2
0.2

income-statement-row.row.net-income

-8.090.221.130.6
25.9
37.7
37.3
23.8
20.6
17.5
18
17.2
16.7
20.9
26
23
20
14.4
12.1
8
5.8
3.3
0.8
-2.8
-1.8
Sarnased aktsiad
Sind võib huvitada ka:
MDVL
MedAvail Holdings, Inc..
1.8 USD
NASDAQ
3544.T
Satudora Holdings Co.,Ltd..
879 JPY
JPX
TSUSF
Tsuruha Holdings Inc..
86.95 USD
PNK
SHPPF
Shop Apotheke Europe N.V..
150.26 USD
PNK
3391.T
Tsuruha Holdings Inc..
11105 JPY
JPX
GABY.CN
GABY Inc..
0.005 CAD
CNQ
ALBHF
Alibaba Health Information Technology Limited.
0.4628 USD
PNK
WLCGF
Welcia Holdings Co., Ltd..
17.49 USD
PNK
1345.HK
China Pioneer Pharma Holdings Limited.
1.42 HKD
HKSE
OXIHF
Oxford Investments Holdings Inc..
0.000001 USD
PNK

Korduma kippuv küsimus

Mis on PetMed Express, Inc. (PETS) koguvara?

PetMed Express, Inc. (PETS) koguvara on 164117000.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on 136315999.000.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.278.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on 0.084.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on -0.029.

Mis on ettevõtte kogutulu?

Kogutulu on -0.043.

Mis on PetMed Express, Inc. (PETS) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on 233000.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 0.000.

Mis on tegevuskulude arv?

Tegevuskulud on 72444000.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 49440000.000.